Akums breaks ground for its first overseas manufacturing facility in Zambia
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
Expanding US operations to address the increased demand for API development and manufacturing
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Investment to expand manufacturing and global medicine supply capacity
Subscribe To Our Newsletter & Stay Updated